Your search returned 240 studies. (Get alerts for new studies):
- A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer
Conditions: Breast Cancer
Location: Everett, California
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Thera
Conditions: Prostate Cancer
Location: Bellingham, Washington
- Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-
Conditions: Metastatic Breast Cancer
Location: Edmonds, Washington
- Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Bellingham, Washington
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Bellingham, Washington
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Everett, Washington
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Mount Vernon, Washington
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Poulsbo, Washington
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Sequim, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Anacortes, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Bellingham, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Everett, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Mount Vernon, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Poulsbo, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Sedro-Woolley, Washington
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: Bellingham, Washington
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: Bellingham, Washington
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: Everett, Washington
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: Mount Vernon, Washington
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: Poulsbo, Washington
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: Sequim, Washington
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Bellingham, Washington
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Everett, Washington
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Mount Vernon, Washington
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Poulsbo, Washington
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Sequim, Washington
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Bellingham, Washington
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Mount Vernon, Washington
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Sequim, Washington
- Connect® MM- The Multiple Myeloma Disease Registry
Conditions: Multiple Myeloma
Location: Bellingham, Washington
- Connect® MM- The Multiple Myeloma Disease Registry
Conditions: Multiple Myeloma
Location: Everett, Washington
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: Anacortes, Washington
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: Bellingham, Washington
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: Everett, Washington
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: Mount Vernon, Washington
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: Poulsbo, Washington
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: Sedro-Woolley, Washington
- A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
Conditions: Oral Mucositis
Location: Bellingham, Washington
- A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
Conditions: Oral Mucositis
Location: Everett, Washington
- Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carbopla
Conditions: Lung Cancer - Non Small Cell
Location: Everett, Washington
- Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Bellingham, Washington
- Randomized Study of Laser and Balloon Angioplasty Versus Balloon Angioplasty to Treat Peripheral In-stent Restenosis
Conditions: Peripheral Arterial Disease
Location: Bellingham, Washington
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Bellingham, Washington
- Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Conditions: Breast Cancer
Location: Everett, Washington
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: Anacortes, Washington
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: Bellingham, Washington
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: Everett, Washington
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: Mount Vernon, Washington
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: Port Angeles, Washington
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: Poulsbo, Washington
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: Sedro-Woolley, Washington
- EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Conditions: Neoplasms, Breast
Location: Mount Vernon, Washington
- Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Mount Vernon, Washington
- Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Sedro-Woolley, Washington
- Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Bellingham, Washington
- Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Anacortes, Washington
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Anacortes, Washington
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Bellingham, Washington
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Mount Vernon, Washington
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Poulsbo, Washington
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Sedro-Woolley, Washington
- Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Prima
Conditions: Brenner Tumor - Fallopian Tube Cancer - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated A
Location: Bellingham, Washington
- Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Prima
Conditions: Brenner Tumor - Fallopian Tube Cancer - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated A
Location: Everett, Washington
- Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Prima
Conditions: Brenner Tumor - Fallopian Tube Cancer - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated A
Location: Mount Vernon, Washington
- Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Prima
Conditions: Brenner Tumor - Fallopian Tube Cancer - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated A
Location: Poulsbo, Washington
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
Location: Port Angeles, Washington
- Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Poulsbo, Washington
- S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Anacortes, Washington
- S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Bellingham, Washington
- S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Mount Vernon, Washington
- S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Poulsbo, Washington
- S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Sedro-Woolley, Washington
- Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer
Conditions: Breast Cancer
Location: Bellingham, Washington
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab Followed By Bevacizumab and Erlotinib Hydrochloride in Treating Patients With M
Conditions: Estrogen Receptor-negative Breast Cancer - HER2-negative Breast Cancer - Progesterone Receptor-negative Breast Cancer - Stage IV Breast Cancer - Triple-negative Breast Cancer
Location: Mount Vernon, Washington
- Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
Conditions: Adult Acute Lymphoblastic Leukemia in Remission - B-cell Adult Acute Lymphoblastic Leukemia - L1 Adult Acute Lymphoblastic Leukemia - L2 Adult Acute Lymphoblastic Leukemia - Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia - R
Location: Anacortes, Washington
- Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
Conditions: Adult Acute Lymphoblastic Leukemia in Remission - B-cell Adult Acute Lymphoblastic Leukemia - L1 Adult Acute Lymphoblastic Leukemia - L2 Adult Acute Lymphoblastic Leukemia - Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia - R
Location: Bellingham, Washington
- Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
Conditions: Adult Acute Lymphoblastic Leukemia in Remission - B-cell Adult Acute Lymphoblastic Leukemia - L1 Adult Acute Lymphoblastic Leukemia - L2 Adult Acute Lymphoblastic Leukemia - Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia - R
Location: Edmonds, Washington
- Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
Conditions: Adult Acute Lymphoblastic Leukemia in Remission - B-cell Adult Acute Lymphoblastic Leukemia - L1 Adult Acute Lymphoblastic Leukemia - L2 Adult Acute Lymphoblastic Leukemia - Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia - R
Location: Mount Vernon, Washington
- Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
Conditions: Adult Acute Lymphoblastic Leukemia in Remission - B-cell Adult Acute Lymphoblastic Leukemia - L1 Adult Acute Lymphoblastic Leukemia - L2 Adult Acute Lymphoblastic Leukemia - Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia - R
Location: Poulsbo, Washington
- Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
Conditions: Adult Acute Lymphoblastic Leukemia in Remission - B-cell Adult Acute Lymphoblastic Leukemia - L1 Adult Acute Lymphoblastic Leukemia - L2 Adult Acute Lymphoblastic Leukemia - Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia - R
Location: Sedro-Woolley, Washington
- A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Conditions: Asthma
Location: Bellingham, Washington
- Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
Conditions: Chronic Heart Failure
Location: Everett, Washington
- Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Conditions: Non-Small Cell Lung Cancer - Anemia - Cancer - Lung Cancer
Location: Edmonds, Washington
- S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Anacortes, Washington
- S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Bellingham, Washington
- S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Everett, Washington
- S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Mount Vernon, Washington
- S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Poulsbo, Washington
- S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Sedro-Woolley, Washington
- Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lympho
Conditions: Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
Location: Edmonds, Washington
- S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Anacortes, Washington
- S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Bellingham, Washington
- S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Everett, Washington
- S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Mount Vernon, Washington
- S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Poulsbo, Washington
- S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Sedro-Woolley, Washington
- Longitudinal Surveillance Registry (LSR) of ACUITY Spiral
Conditions: Heart Failure
Location: Bellingham, Washington
- Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma - Stage III Adult Diffuse Large Cell Lymphoma - Stage IV Adult Diffuse Large Cell Lymphoma
Location: Anacortes, Washington
- Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma - Stage III Adult Diffuse Large Cell Lymphoma - Stage IV Adult Diffuse Large Cell Lymphoma
Location: Bellingham, Washington
- Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma - Stage III Adult Diffuse Large Cell Lymphoma - Stage IV Adult Diffuse Large Cell Lymphoma
Location: Mount Vernon, Washington
- Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma - Stage III Adult Diffuse Large Cell Lymphoma - Stage IV Adult Diffuse Large Cell Lymphoma
Location: Poulsbo, Washington
- Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma - Stage III Adult Diffuse Large Cell Lymphoma - Stage IV Adult Diffuse Large Cell Lymphoma
Location: Sedro-Woolley, Washington
- Statins for Acutely Injured Lungs From Sepsis
Conditions: Sepsis Induced ALI
Location: Everett, Washington
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma - Advanced Adult Primary Liver Cancer - Localized Unresectable Adult Primary Liver Cancer - Recurrent Adult Primary Liver Cancer
Location: Everett, Washington
- Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Everett, Washington
- Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Canc
Conditions: Lung Cancer
Location: Anacortes, Washington
- Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Canc
Conditions: Lung Cancer
Location: Bellingham, Washington
- Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Canc
Conditions: Lung Cancer
Location: Mount Vernon, Washington
- Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Canc
Conditions: Lung Cancer
Location: Poulsbo, Washington
- Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Canc
Conditions: Lung Cancer
Location: Sedro-Woolley, Washington
- Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Advanced Malignant Mesothelioma - Epithelial Mesothelioma - Recurrent Malignant Mesothelioma - Sarcomatous Mesothelioma
Location: Anacortes, Washington
- Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Advanced Malignant Mesothelioma - Epithelial Mesothelioma - Recurrent Malignant Mesothelioma - Sarcomatous Mesothelioma
Location: Bellingham, Washington
- Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Advanced Malignant Mesothelioma - Epithelial Mesothelioma - Recurrent Malignant Mesothelioma - Sarcomatous Mesothelioma
Location: Mt. Vernon, Washington
- Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Advanced Malignant Mesothelioma - Epithelial Mesothelioma - Recurrent Malignant Mesothelioma - Sarcomatous Mesothelioma
Location: Poulsbo, Washington
- Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Advanced Malignant Mesothelioma - Epithelial Mesothelioma - Recurrent Malignant Mesothelioma - Sarcomatous Mesothelioma
Location: Sedro-Woolley, Washington
- Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Conditions: Chronic Lymphocytic Leukemia
Location: Bellingham, Washington
- Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Conditions: Chronic Lymphocytic Leukemia
Location: Everett, Washington
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: Everett, Washington
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Conditions: Breast Cancer
Location: Anacortes, Washington
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Conditions: Breast Cancer
Location: Bellingham, Washington
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Conditions: Breast Cancer
Location: Mount Vernon, Washington
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Conditions: Breast Cancer
Location: Poulsbo, Washington
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Conditions: Breast Cancer
Location: Sedro-Woolley, Washington
- Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
Conditions: Thrombocytopaenia
Location: Edmunds, Washington
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Anacortes, Washington
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Bellingham, Washington
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Mount Vernon, Washington
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Poulsbo, Washington
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Sedro-Woolley, Washington
- Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary P
Conditions: Brenner Tumor - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated Adenocarcinoma - Stage II
Location: Bellingham, Washington
- Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary P
Conditions: Brenner Tumor - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated Adenocarcinoma - Stage II
Location: Everett, Washington
- Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary P
Conditions: Brenner Tumor - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated Adenocarcinoma - Stage II
Location: Mount Vernon, Washington
- Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary P
Conditions: Brenner Tumor - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated Adenocarcinoma - Stage II
Location: Poulsbo, Washington
- Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
Conditions: Childhood Mixed Glioma - Untreated Childhood Brain Stem Glioma
Location: Anacortes, Washington
- Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
Conditions: Childhood Mixed Glioma - Untreated Childhood Brain Stem Glioma
Location: Bellingham, Washington
- Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
Conditions: Childhood Mixed Glioma - Untreated Childhood Brain Stem Glioma
Location: Mount Vernon, Washington
- Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
Conditions: Childhood Mixed Glioma - Untreated Childhood Brain Stem Glioma
Location: Poulsbo, Washington
- Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
Conditions: Childhood Mixed Glioma - Untreated Childhood Brain Stem Glioma
Location: Sedro-Woolley, Washington
- Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
Conditions: Adenocarcinoma of the Esophagus - Adenocarcinoma of the Gastroesophageal Junction - Stage IB Esophageal Cancer - Stage IIA Esophageal Cancer - Stage IIB Esophageal Cancer - Stage IIIA Esophageal Cancer - Stage IIIB Esophageal Cancer
Location: Bellingham, Washington
- Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Can
Conditions: Ovarian Clear Cell Cystadenocarcinoma - Stage III Ovarian Epithelial Cancer - Stage IV Ovarian Epithelial Cancer
Location: Bellingham, Washington
- Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Can
Conditions: Ovarian Clear Cell Cystadenocarcinoma - Stage III Ovarian Epithelial Cancer - Stage IV Ovarian Epithelial Cancer
Location: Everett, Washington
- Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Can
Conditions: Ovarian Clear Cell Cystadenocarcinoma - Stage III Ovarian Epithelial Cancer - Stage IV Ovarian Epithelial Cancer
Location: Mount Vernon, Washington
- Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Can
Conditions: Ovarian Clear Cell Cystadenocarcinoma - Stage III Ovarian Epithelial Cancer - Stage IV Ovarian Epithelial Cancer
Location: Poulsbo, Washington
- CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Conditions: Chronic Myelogenous Leukemia in Chronic Phase
Location: Everett, Washington
- Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance
Conditions: Prostate Cancer
Location: Everett, Washington
- A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001 AM2)
Conditions: Clostridium Difficile Infection
Location: Everett, Washington
- Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Bellingham, Washington
- Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Adenocarcinoma of the Stomach - Recurrent Esophageal Cancer - Recurrent Gastric Cancer
Location: Anacortes, Washington
- Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Adenocarcinoma of the Stomach - Recurrent Esophageal Cancer - Recurrent Gastric Cancer
Location: Bellingham, Washington
- Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Adenocarcinoma of the Stomach - Recurrent Esophageal Cancer - Recurrent Gastric Cancer
Location: Mount Vernon, Washington
- Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Adenocarcinoma of the Stomach - Recurrent Esophageal Cancer - Recurrent Gastric Cancer
Location: Poulsbo, Washington
- Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Adenocarcinoma of the Stomach - Recurrent Esophageal Cancer - Recurrent Gastric Cancer
Location: Sedro-Woolley, Washington
- Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer
Conditions: Dysphagia - Lung Cancer - Pain
Location: Bellingham, Washington
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Conditions: Recurrent Melanoma - Stage IIIB Melanoma - Stage IIIC Melanoma - Stage IV Melanoma
Location: Bellingham, Washington
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Conditions: Recurrent Melanoma - Stage IIIB Melanoma - Stage IIIC Melanoma - Stage IV Melanoma
Location: Edmonds, Washington
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Conditions: Recurrent Melanoma - Stage IIIB Melanoma - Stage IIIC Melanoma - Stage IV Melanoma
Location: Everett, Washington
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Anacortes, Washington
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Bellingham, Washington
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Edmonds, Washington
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Edmonds, Washington
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Everett, Washington
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Mount Vernon, Washington
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Mount Vernon, Washington
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Poulsbo, Washington
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Sedro-Woolley, Washington
- Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
Conditions: Breast Cancer - Depression - Fatigue - Sleep Disorders
Location: Everett, Washington
- Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer
Conditions: Colorectal Cancer
Location: Edmonds, Washington
- S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
Conditions: Prostate Cancer
Location: Everett, Washington
- Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-S
Conditions: Lung Cancer
Location: Everett, Washington
- Higher-Dose Radiation Therapy or Standard Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Conditions: Breast Cancer
Location: Mount Vernon, Washington
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Anacortes, Washington
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Bellingham, Washington
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Mount Vernon, Washington
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Poulsbo, Washington
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Sedro-Woolley, Washington
- Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Conditions: Peripheral Arterial Disease - Claudication
Location: Bellingham, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Anacortes, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Bellingham, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Everett, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Mount Vernon, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Poulsbo, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Sedro-Woolley, Washington
- A Study of Brentuximab Vedotin in Relapsed or Refractory CD30-positive Non-Hodgkin Lymphoma
Conditions: Lymphoma, B-Cell - Lymphoma, Large B-Cell, Diffuse - Lymphoma, Non-Hodgkin - Lymphoma, T-Cell
Location: Edmonds, Washington
- Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer
Conditions: Breast Cancer - Cancer Survivor - Hot Flashes
Location: Bellingham, Washington
- Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Conditions: Acute Lymphoid Leukemia - Acute Myeloid Leukemia - Chronic Lymphocytic Leukemia - Multiple Myeloma - Solid Tumors
Location: Edmonds, Washington
- Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal
Conditions: Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer
Location: Bellingham, Washington
- Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal
Conditions: Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer
Location: Everett, Washington
- Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal
Conditions: Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer
Location: Mount Vernon, Washington
- Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal
Conditions: Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer
Location: Poulsbo, Washington
- S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer - Gastric Cancer
Location: Anacortes, Washington
- S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer - Gastric Cancer
Location: Bellingham, Washington
- S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer - Gastric Cancer
Location: Everett, Washington
- S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer - Gastric Cancer
Location: Mount Vernon, Washington
- S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer - Gastric Cancer
Location: Poulsbo, Washington
- S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer - Gastric Cancer
Location: Sedro-Woolley, Washington
- S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer
Conditions: Breast Cancer
Location: Anacortes, Washington
- S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer
Conditions: Breast Cancer
Location: Bellingham, Washington
- S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer
Conditions: Breast Cancer
Location: Mount Vernon, Washington
- S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer
Conditions: Breast Cancer
Location: Poulsbo, Washington
- S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer
Conditions: Breast Cancer
Location: Sedro-Woolley, Washington
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Anacortes, Washington
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Bellingham, Washington
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Edmonds, Washington
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Edmonds, Washington
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Everett, Washington
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Mount Vernon, Washington
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Poulsbo, Washington
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Sedro-Woolley, Washington
- Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain
Conditions: Chronic Low Back Pain
Location: Edmonds, Washington
- Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
Conditions: Colorectal Cancer
Location: Bellingham, Washington
- Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis
Conditions: Relapsing Remitting Multiple Sclerosis
Location: Bellingham, Washington
- Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Conditions: Abdominal Aortic Aneurysm - Aorto-iliac Aneurysm
Location: Everett, Washington
- Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer
Conditions: Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage IV Pancreatic Cancer
Location: Anacortes, Washington
- A Randomized, Controlled Study Evaluating the Efficacy and Safety of GS-1101 (CAL-101) in Combination With Ofatumumab for Previously Treated Chronic L
Conditions: Chronic Lymphocytic Leukemia
Location: Everett, Washington
- Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrill
Conditions: Atrial Fibrillation
Location: Bellingham, Washington
- Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain
Conditions: Neuropathic Pain
Location: Edmonds, Washington
- A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Conditions: Breast Cancer
Location: Edmonds, Washington
- Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot be Removed by Su
Conditions: Childhood Renal Cell Carcinoma - Recurrent Renal Cell Cancer - Stage III Renal Cell Cancer - Stage IV Renal Cell Cancer - Type 1 Papillary Renal Cell Carcinoma - Type 2 Papillary Renal Cell Carcinoma
Location: Anacortes, Washington
- Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot be Removed by Su
Conditions: Childhood Renal Cell Carcinoma - Recurrent Renal Cell Cancer - Stage III Renal Cell Cancer - Stage IV Renal Cell Cancer - Type 1 Papillary Renal Cell Carcinoma - Type 2 Papillary Renal Cell Carcinoma
Location: Bellingham, Washington
- Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot be Removed by Su
Conditions: Childhood Renal Cell Carcinoma - Recurrent Renal Cell Cancer - Stage III Renal Cell Cancer - Stage IV Renal Cell Cancer - Type 1 Papillary Renal Cell Carcinoma - Type 2 Papillary Renal Cell Carcinoma
Location: Mount Vernon, Washington
- Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot be Removed by Su
Conditions: Childhood Renal Cell Carcinoma - Recurrent Renal Cell Cancer - Stage III Renal Cell Cancer - Stage IV Renal Cell Cancer - Type 1 Papillary Renal Cell Carcinoma - Type 2 Papillary Renal Cell Carcinoma
Location: Poulsbo, Washington
- Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot be Removed by Su
Conditions: Childhood Renal Cell Carcinoma - Recurrent Renal Cell Cancer - Stage III Renal Cell Cancer - Stage IV Renal Cell Cancer - Type 1 Papillary Renal Cell Carcinoma - Type 2 Papillary Renal Cell Carcinoma
Location: Sedro-Woolley, Washington
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Mount Vernon, Washington
- ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
Conditions: Neoplasms, Breast - Breast Cancer
Location: Bellingham, Washington
- Continuing Access To AG- 013736 (A406) For Patients Previously Receiving AG 013736 In Clinical Trials
Conditions: Solid Tumors
Location: Everett, Washington
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Anacortes, Washington
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Bellingham, Washington
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Edmonds, Washington
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Everett, Washington
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Mount Vernon, Washington
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Poulsbo, Washington
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Sedro-Woolley, Washington
- A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Conditions: Advanced Prostate Cancer - Prostatic Neoplasms
Location: Poulsbo, Washington
- EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer
Conditions: Ovarian Cancer Recurrent
Location: Mount Vernon, Washington
- Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer
Conditions: Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage IV Pancreatic Cancer
Location: Bellingham, Washington
- Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer
Conditions: Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage IV Pancreatic Cancer
Location: Edmonds, Washington
- Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer
Conditions: Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage IV Pancreatic Cancer
Location: Mount Vernon, Washington
- Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer
Conditions: Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage IV Pancreatic Cancer
Location: Poulsbo, Washington
- Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer
Conditions: Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage IV Pancreatic Cancer
Location: Sedro-Woolley, Washington
- A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Br
Conditions: Breast Cancer
Location: Mount Vernon, Washington
|